Inventor · disambiguated record
Alain Vicari
Also filed as: VICARI ALAIN · VICARI ALAIN P
14 granted patents·15 pending applications·58 citations·filing 2001–2022
91Inventor score
Files withSCHERING CORP16MERCK PATENT GMBH3CALYPSO BIOTECH SA2SCHERING CORP CANJI INC2COLEY PHARM GROUP INC1
Top patents by PatentIndex Score
29 records- 0193US10301384B2Antibodies to IL-15CALYPSO BIOTECH SA·Filed 2015·Granted May 28, 2019·18 cites·11 claims
- 0288US6723520B2Antibodies that bind chemokine teckSCHERING CORP·Filed 2002·Granted Apr 20, 2004·11 cites·22 claims
- 0385US11130806B2Antibodies to IL-15 and uses thereofCALYPSO BIOTECH SA·Filed 2019·Granted Sep 28, 2021·3 cites·16 claims
- 0485US7279460B2Chemokine TECK polypeptidesSCHERING CORP·Filed 2004·Granted Oct 9, 2007·7 cites·7 claims
- 0580US10829552B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using sameMERCK PATENT GMBH·Filed 2018·Granted Nov 10, 2020·1 cites·14 claims
- 0677US7276238B2Methods for using chemokine teckSCHERING CORP·Filed 2004·Granted Oct 2, 2007·2 cites·20 claims
- 0777US7101987B2CCL27 polypeptidesSCHERING CORP·Filed 2002·Granted Sep 5, 2006·6 cites·9 claims
- 0876US10017568B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using sameROMMELAERE HEIDI·Filed 2012·Granted Jul 10, 2018·3 cites·13 claims
- 0975US6737252B27 transmembrane receptor family member BLRXSCHERING CORP·Filed 2001·Granted May 18, 2004·4 cites·16 claims
- 1075US2010068763A1Mammalian chemokines; receptors; reagents; usesSCHERING CORP CANJI INC·Filed 2009·Application pending·0 cites
- 1174US2010086560A1Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2009·Application pending·0 cites
- 1274US2022195031A1Amino acid sequences directed against il-17a, il-17f and/or il-17a/f and polypeptides comprising the sameMERCK PATENT GMBH·Filed 2022·Application pending·0 cites
- 1373US7217700B2Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2001·Granted May 15, 2007·3 cites·11 claims
- 1472US11773159B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using sameMERCK PATENT GMBH·Filed 2020·Granted Oct 3, 2023·0 cites·15 claims
- 1570US2008107643A1Mammalian chemokines; receptors; reagents; usesSCHERING CORP CANJI INC·Filed 2007·Application pending·0 cites
- 1670US2009191629A1Mammalian chemokine reagentsSCHERING CORP·Filed 2009·Application pending·0 cites
- 1768US2007166280A1Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2007·Application pending·0 cites
- 1866US7307146B2Dnaxccr10SCHERING CORP·Filed 2006·Granted Dec 11, 2007·0 cites·7 claims
- 1966US2008044835A1Mammalian chemokine reagentsWANG WEI·Filed 2007·Application pending·0 cites
- 2063US2007128159A1Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2007·Application pending·0 cites
- 2162US8119786B2Nucleic acids encoding CCL27VICARI ALAIN·Filed 2009·Granted Feb 21, 2012·0 cites·11 claims
- 2262US2004203080A17 transmembrane receptor family member BLRxFiled 2004·Application pending·0 cites
- 2360US7601815B2Anti-CCL27 antibodiesSCHERING CORP·Filed 2006·Granted Oct 13, 2009·0 cites·22 claims
- 2459US2003077247A1Chemokines as adjuvants of immune responseSCHERING CORP·Filed 2002·Application pending·0 cites
- 2556US2003138413A1Methods for treating cancerSCHERING CORP·Filed 2002·Application pending·0 cites
- 2654US2009087440A1Methods for Treating CancerSCHERING CORP·Filed 2008·Application pending·0 cites
- 2746US2010189772A1Compositions of TLR ligands and antiviralsCOLEY PHARM GROUP INC·Filed 2007·Application pending·0 cites
- 2841US2003008840A1Methods for treating cancerSCHERING CORP·Filed 2002·Application pending·0 cites
- 2931US2002103361A1Mammalian chemokines; receptors; reagents; usesFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →